ZOLISTRA 4MG INJECTION

Zolistra 4mg injection is a potent ingredient Zoledronic Acid. It is part of the class of substances known as bisphosphonates. It’s used to lower the amount of calcium in patients with excessive levels of blood because of tumors. Tumors can speed up regular bone changes where calcium release from bone increases. This is referred to as tumor-inducing hypercalcemia (TIH). It can also be utilized to avoid bone-related complications in adults with multiple myeloma as well as bone metastases due to cancerous solid tumors (spread in cancer that extends from the site of origin into the bones) in addition to conventional cancer treatment.
Zolistra 4mg injection is also recommended to treat or prevent osteoporosis (a condition where bones are weak and thin and can break easily) for women who have gone through menopausal changes. It can also be employed to combat osteoporosis in males. It’s used to treat Paget’s disease of the bone (a condition where bones are weak and soft and can be deformed and painful or fractured). Other applications include the prevention or treatment of osteoporosis for women and men taking glucocorticoids (a corticosteroid medication that can result in osteoporosis).
Do not use this medicine if you’re allergic to zoledronic acids, bisphosphonate, or any other component of this medication or when you are pregnant or nursing. Before beginning treatment, notify your doctor of any liver or kidney issues, bone conditions, swelling, pain, or numb jaw. This medication is not recommended for use by adolescents and children younger than 18 years old. Zolistra 4 mg injection is not chemotherapy for cancer, and it will not slow or stop the progression of cancer. It can, however, be utilized to treat bone disease in cancer patients.